fda compounding glp-1 enforcement news today 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Safe use of compounded GLP
Description
No Commitment - Pause or Cancel Anytime

Women report Ozempic breasts sagging, deflated, or swollen breasts after rapid fat loss
Your employer could cover your GLP-1 with no insurance, no prior auth
Helpful tips and info about your Surest pharmacy benefit.
That's why we are urging the FDA to strengthen safeguards and help ensure patients have access to medicines that meet rigorous quality and safety standards

Discover the clinical guidance, potential interactions, side effects to monitor, and essential medical considerations when combining this SSRI antidepressant with semaglutide for weight management.
